As a healthy, 36-year-old gynecological oncologist, Deanna Gerber, M.D. never saw her cancer diagnosis coming. However, in January 2021, she was diagnosed with triple-negative breast cancer.
Breast cancer is the most common cancer in women worldwide. In the United States, a woman has a 1 in 8 chance she will be diagnosed during her lifetime. Between 10% and 20% of cases are considered triple-negative breast cancer. Triple-negative breast cancer cells lack receptors for estrogen, progesterone and human epidermal growth factor receptor 2, making them less responsive to hormonal therapies and more aggressive.
After her diagnosis, Gerber froze her eggs and underwent a double mastectomy, 20 weeks of chemotherapy and six weeks of radiation.
Today, she is in remission and is using the less